resTORbio, Inc.

Home » resTORbio, Inc.

IPO

resTORbio, Inc.

They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.

Symbol

TORC

Price Range
TBD

Anticipated Shares
5,670,000

Effective Date
January 26, 2018

Underwriters
BofA Merrill Lynch, Leerink Partners, Evercore ISI, Wedbush PacGrow

To view the prospectus for resTORbio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253